Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Ornithine

Amino-acidBest before bedBest taken away from food

Useful mainly for people with hepatic encephalopathy (as L-ornithine L-aspartate, under medical care).

Quick decision guide

May help most

people with hepatic encephalopathy (as L-ornithine L-aspartate, under medical care)

Common dosing range

500–2,000 mg/day for general use

When to expect effects

Hours (ammonia) to weeks (fatigue/sleep)

Watch out for

use only under supervision in liver or kidney disease

What is it

Ornithine is a non-essential, non-protein amino acid central to the urea cycle, where it enables the body to convert toxic ammonia to urea for excretion. It is also a precursor to polyamines involved in cell growth and tissue repair.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You have hepatic encephalopathy and a clinician is dosing LOLA
You want to trial it for exercise fatigue or sleep/stress and accept modest evidence

Probably skip if

You are seeking growth hormone-driven muscle gains
You expect strong, reliable effects on sleep or recovery
You have liver or kidney disease and are self-dosing without supervision

Evidence at a glance

hepatic encephalopathy (as LOLA)

Good Evidence
Effect
Moderate
Best fit
patients with cirrhosis and hepatic encephalopathy
Time
Hours to days

exercise fatigue

Limited Evidence
Effect
Small
Best fit
people experiencing exertional fatigue
Time
During/after exercise

sleep and stress

Limited Evidence
Effect
Small
Best fit
adults with stress-related poor sleep
Time
Days to weeks

growth hormone elevation

Mixed Evidence
Effect
Variable, transient
Best fit
studied for transient hormonal response, not body composition
Time
Acute

Evidence for 4 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

hepatic encephalopathy (as LOLA)

Disease adjunct
Good Evidence

L-ornithine L-aspartate lowers blood ammonia by supporting the urea cycle and glutamine synthesis, and randomized trials show improvement in hepatic encephalopathy grade and mental status. It is an established adjunct in hepatology, used intravenously or orally. Dosing must be individualized by a clinician.

Effect size
Moderate
Time to effect
Hours to days
Best fit
patients with cirrhosis and hepatic encephalopathy
Less likely
healthy people seeking general detox benefits

Bottom line: A genuine therapeutic use, but only as supervised LOLA therapy for liver-related hyperammonemia.

exercise fatigue

Supplement benefit
Limited Evidence

Small trials suggest ornithine may reduce perceived fatigue during prolonged or repeated exercise, possibly by aiding ammonia clearance. Sample sizes are modest and results are inconsistent. The effect, if present, is small.

Effect size
Small
Time to effect
During/after exercise
Best fit
people experiencing exertional fatigue

Bottom line: May modestly blunt exercise fatigue, but evidence is preliminary.

sleep and stress

Supplement benefit
Limited Evidence

A few small trials report ornithine improved subjective sleep quality and lowered stress markers such as the cortisol/DHEA-S ratio. The evidence base is limited to a small number of studies. Effects are modest and not well replicated.

Effect size
Small
Time to effect
Days to weeks
Best fit
adults with stress-related poor sleep

Bottom line: Some early support for stress and sleep, but far from established.

growth hormone elevation

Biomarker support
Mixed Evidence

High oral or intravenous ornithine doses can transiently raise growth hormone, but this is an inconsistent biomarker response that does not translate into demonstrated changes in muscle or body composition. It is frequently marketed beyond what the data support. This is a biomarker effect only.

Effect size
Variable, transient
Time to effect
Acute
Best fit
studied for transient hormonal response, not body composition
Less likely
people expecting muscle growth or fat loss from GH spikes

Bottom line: Any growth hormone bump is a short-lived biomarker change with no proven physique benefit.

How it works

Ornithine is produced from arginine by the enzyme arginase, primarily in the liver. Within the urea cycle, ornithine combines with carbamoyl phosphate (carrying nitrogen from ammonia) to form citrulline. Citrulline ultimately yields urea (excreted in urine) and regenerates ornithine for another cycle. This pathway is the body's main route for handling nitrogen waste from amino acid breakdown. Ornithine is also decarboxylated to putrescine, the first step in polyamine synthesis. Polyamines (putrescine, spermidine, spermine) support DNA replication, cell proliferation, and tissue regeneration, making ornithine relevant to wound healing and growth. Supplemental ornithine is most established clinically in liver disease (as L-ornithine L-aspartate for hyperammonemia) and is marketed for athletic recovery, fatigue, and sleep support, with more modest evidence in those areas.

How to take it

1. Typical dose
500–2,000 mg/day for general use
2. Higher studied dose
6–9 g/day as L-ornithine L-aspartate for hepatic encephalopathy
3. Timing
Post-exercise for recovery; 30–60 min before bed for sleep
4. With food
On an empty stomach for best absorption
5. Split dosing
Split across the day for general urea-cycle support
6. How long to try
Trial 2–4 weeks for fatigue or sleep effects

What to track

perceived recovery/fatigue
sleep quality
morning alertness
GI tolerance

3 commercial forms

Compare the main delivery options and what they’re best suited for.

L-ornithine HCl

Most common in retail supplements.

Standard supplement form; well absorbed.

L-ornithine L-aspartate (LOLA)

The form studied for hepatic encephalopathy. Available by prescription in many countries.

Combined with aspartate for higher-dose clinical use.

L-ornithine alpha-ketoglutarate (OKG)

Studied for nitrogen balance in surgical and burn patients.

Combined with alpha-ketoglutarate; used in clinical nutrition.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

GI cramping and diarrhea at high doses

Who should avoid it

  • people with liver or kidney disease self-dosing without supervision
  • those during active herpes simplex flares (theoretical)

Pregnancy & breastfeeding

Use caution in pregnancy and lactation; not well studied.

Interactions

lactulose/rifaximin (ammonia-lowering drugs)Moderate

overlapping action on ammonia; coordinate with a clinician

arginine and lysineMinor

competes for amino acid transporters at high doses

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

L-ornithine HCl with clear elemental dose
LOLA form if targeting liver support under care
third-party purity testing

Be skeptical of

'boosts growth hormone for muscle'
'detoxifies the liver' in healthy people
'guaranteed deeper sleep'

Frequently asked questions

Where does ornithine come from in the body?

It is produced in the liver from arginine by the enzyme arginase. Ornithine then participates in the urea cycle to dispose of nitrogen waste as urea.

Will ornithine help me recover faster from workouts?

Small studies suggest possible reductions in fatigue and ammonia accumulation. Effects are modest. Sleep, nutrition, and training load have far bigger impact on recovery.

Can ornithine help with sleep?

Some small studies suggest 400 mg before bed may modestly improve sleep quality. Effects are subtle and individual.

Is ornithine safe in liver disease?

Under medical supervision, ornithine (as LOLA) is actually used to help lower ammonia in hepatic encephalopathy. Self-supplementing in liver disease is not recommended without clinician input.

Should I take ornithine with arginine?

Combination products are common. They share absorption transporters, so very high doses of one can reduce uptake of the other, but typical combination doses work fine.

References by claim

hepatic encephalopathy (as LOLA)

Jiang et al., 2009PubMed (2009) link

Goh et al., 2018PMC (2018) link

exercise fatigue

Nagayama et al., 2025PMC (2025) link

Mikulski et al., 2015PubMed (2015) link

sleep and stress

Miyake et al., 2014PMC (2014) link

Moriyasu et al., 2024PMC (2024) link

growth hormone elevation

Coker-Gurkan et al., 2022PubMed (2022) link

Track Ornithine with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.